Crowdfunding Has Never Been This Easy

Invst Guru is your bi-weekly digest that explores the dynamics of equity crowdfunding. Delivered every Wednesday and Sunday, we connect startups with the power of the crowd and provide investors with access to groundbreaking ventures.

In each issue of Invst Guru, we'll spotlight the latest trends, share success stories, and offer insights from industry leaders. We aim to equip you with the knowledge and opportunities to participate effectively in equity crowdfunding, whether you're looking to fund your innovative startup or invest in potential unicorns.

Tombot - Makes Pets For People Who Can’t Have Pets

Tombot creates robotic therapy puppies for individuals who cannot have live pets due to health, financial, or situational restrictions. The company's flagship product, Jennie, is a high-tech robotic companion designed to help those suffering from mental health challenges, including dementia, autism, anxiety, and depression. Tombot uniquely blends art, science, and engineering to provide a non-pharmacological solution to alleviate symptoms like loneliness and anxiety.

Key Investment Details

• Current Raise: $29,977 raised

• Days Left: 56

• Target Amount: $2,000,000.22

• Investment Security: Series Seed Prime-2 Preferred Stock, priced at $1.03505 per share

• Minimum Investment: $249.45

Business Proposition

• Problem: Over 55 million people globally suffer from dementia, often facing loneliness, depression, and anxiety. Psychotropic and opioid medications are commonly used but come with severe side effects.

• Solution: Jennie, the robotic therapy puppy, provides comfort, companionship, and helps manage symptoms without medication. Tombot’s approach leverages realism in design, collaborating with Jim Henson’s Creature Shop for lifelike appearance and behaviors.

• Market Potential: The product is aimed initially at the U.S. dementia care market, with over 7,000 pre-orders and international interest from hospitals and healthcare facilities.

Reasons to Invest

1. Experienced leadership team with a history of successful exits in high-tech industries.

2. Over $7.9 million raised in equity funding and a $2 million credit line for manufacturing.

3. Dual business model: Direct-to-Consumer (B2C) and Business-to-Business (B2B2C) with subscription revenue.

4. Artistic collaboration with Jim Henson’s Creature Shop, known for creating iconic designs.

5. Recognized by TIME as one of the 100 Best Inventions in 2020 and a winner of Aging2.0's competition for reducing social isolation.

6. Extensive pre-orders and waitlist from individuals and B2B customers across 86 countries.

7. Partnerships for clinical research with organizations like the Cleveland Clinic and Children’s Hospital of LA.

Product Highlights

• Jennie the Robotic Puppy: Engineered for realism in texture, appearance, and behavior to provide emotional and psychological support.

• Impact: Addresses the needs of seniors, veterans, and individuals with autism or PTSD, reducing reliance on medication through interactive, therapeutic companionship.

Business Model and Traction

• B2C & B2B2C Models: Revenue through direct sales and partnerships with healthcare facilities. Plans to integrate health monitoring and seek insurance reimbursement.

• Traction: Strong customer interest and global media exposure. Clinical studies and partnerships with top-tier institutions are underway.

• Market Strategy: Initial focus on dementia care, expanding into other mental health sectors, and international markets.

Future Plans and Liquidity Event

• Product Development: Alpha/Beta testing in 2024, full-scale launch at CES 2025, and first shipments later that year.

• Projected Investor Returns: Expecting significant growth and a liquidity event by 2027.

Investment Bonuses Investors receive tiered perks based on their investment amount, such as waitlist priority, exclusive calls, investor newsletters, and invitations to major events.

Risk Disclaimer: Investments are speculative and illiquid, involving a high risk of loss. Investors should review the Offering Statement and consider the forward-looking nature of projections.